Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

65.94
Delayed Data
As of Apr 28
 -0.13 / -0.20%
Today’s Change
55.06
Today|||52-Week Range
68.12
+5.30%
Year-to-Date
AbbVie Reports Humira Sales Growth in 1st Quarter
Apr 28 / GuruFocus News - Paid Partner Content
Surveying the NASH Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
Cadence Bank Na Buys Wyndham Worldwide, Host Hotels & Resorts, GGP, Sells Schlumberge...
Apr 28 / GuruFocus News - Paid Partner Content
Surveying the NASH Liver-Disease Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
LaFleur & Godfrey LLC Buys Vulcan Materials Co, Copart, Apache, Sells AbbVie, Harman ...
Apr 28 / GuruFocus News - Paid Partner Content
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY
Apr 26 / Zacks.com - Paid Partner Content
AbbVie's Humira Revenue Up 15% Despite Patent Cliff Fears
Apr 28 / GuruFocus News - Paid Partner Content
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Apr 25 / Zacks.com - Paid Partner Content
Cramer: When Oil Falls, These Dominoes Get Hit
Apr 27 / TheStreet.com - Paid Partner Content
Sawgrass Asset Management Llc Buys Nike, Illinois Tool Works, The Cooper, Sells Dolla...
Apr 25 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Apr 27 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong
Apr 25 / Zacks.com - Paid Partner Content
Hennessy Advisors Inc Buys VF, Coca-Cola Co, Plains GP Holdings LP, Sells Spectra Ene...
Apr 27 / GuruFocus News - Paid Partner Content
Breaking Down the 2-Stage Dividend Discount Model for Beginners
Apr 24 / GuruFocus News - Paid Partner Content
AbbVie Is Flexing Its Abs
Apr 27 / TheStreet.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Beats Earnings and Revenue in Q1
Apr 27 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Apr 21 / Zacks.com - Paid Partner Content
A Trio of Stocks Up on Nice Results
Apr 27 / TheStreet.com - Paid Partner Content
What's in Store for AbbVie (ABBV) this Earnings Season?
Apr 21 / Zacks.com - Paid Partner Content
Early-Morning Earnings Extravaganza
Apr 27 / TheStreet.com - Paid Partner Content
What's in Store for Biogen (BIIB) this Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Stocks Dazed After Trump NAFTA Flop, Tax Plan Disappointment; ECB Looms
Apr 27 / Investing Channel - Paid Partner Content
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Apr 20 / Zacks.com - Paid Partner Content
Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids
Apr 27 / TheStreet.com - Paid Partner Content
FDA arthritis drug rejection hits Eli Lilly shares
Apr 17 / FT.com - Paid Partner Content
5 Fantastic Earnings Charts
Apr 26 / Zacks.com - Paid Partner Content